Figure 3.
Subjective severity of symptoms before and after taking the first dose of No-Spa by symptoms. p-values from the Wilcoxon test comparing symptom severity before and after drotaverine were <0.01 for all symptoms.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.